Home › Graft-Versus-Host Disease › Tennessee › Nashville
Graft-Versus-Host Disease clinical trials in Nashville, TN
3 studies for Graft-Versus-Host Disease are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
RecruitingPhase 2
- Vanderbilt University, Ingram Cancer Center, Nashville
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
RecruitingPhase 3
- Sarah Cannon, Nashville
- Vanderbilt Medical Center, Nashville
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RecruitingPhase 2
- Tristar Bone Marrow Transplant, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
Graft-Versus-Host Disease trials in other cities
- Boston, MA10 studies
- New York City, NY7 studies
- Columbus, OH6 studies
- Baldwin Park, CA5 studies
- Atlanta, GA5 studies
- Washington, DC5 studies
- Pittsburgh, PA4 studies
- Tampa, FL4 studies
- Portland, OR4 studies
- St. Louis, MO4 studies
- Detroit, MI4 studies
- Seattle, WA4 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer81 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.